Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Product & Service Announcements

AirProducts: Mechanical v Liquid Nitrogen Sample Freezers

Nitrogen vapour freezers, an alternative to ULT Mechanical freezers? Both methods of long-term, ultra-low temperature sample storage have their pros and cons. But which is better?

Read the rest of entry »

The Cost of Mechanical Ultra-Low Temperature Freezers

ULT or ultra-low temperature sample freezers are found in bio-banks and labs everywhere. But few people know the impact these freezers have on both the environment and your wallet.

Read the rest of entry »

Data Magik launches our latest version of clinical trial system “Kapture”

Data Magik is proud to announce the launch of our latest version of clinical trial system “Kapture” and brand new website (www.datakapture.co.uk).

Read the rest of entry »

RSSL launches sterility testing service

Reading Scientific Services Ltd (RSSL) has expanded its microbiology capabilities with the launch of a fast, responsive and flexible sterility testing service for pharmaceutical and medical device companies.

Following the opening of its state-of-the-art microbiology laboratory earlier this year, RSSL has launched a sterility testing service in response to sustained client demand and market growth. The move enables the leading contract research organisation (CRO) to further enhance the scope of its biopharmaceutical services and increase testing capacity. 

“Over the last five years, our pharmaceutical analytical services have experienced tremendous growth, so entering the sterility market is a strategically sound step. It builds on our already diverse range of services which, together with our reputation for quality and scientific excellence, is a compelling combination - particularly for clients who are keen to work with one trusted laboratory.  

“Not only that, in addition to a standard 21-day timeframe for this service, we are also offering clients an expedited 16-day and 14-day, which we believe to be one of the one of the quickest available on the market today,” says Reginald Fernandes, microbiology laboratory manager at RSSL.

RSSL’s new service encompasses two sterility test methods; membrane filtration for aqueous, alcohol, solvent and oil-based products, as well as direct inoculation for non-solubles.  Both are used to determine the presence or absence of contaminating micro-organisms in terminally sterilised or aseptic filtered drug products, in accordance with Ph. Eur, JP and USP regulations.  

Its introduction has been facilitated by further investment in a purpose-designed sterility testing suite, featuring a Grade D clean room installed by Connect2Clean rooms with Grade A Bioquell isolators. The new laboratory is expected to be fully operational from February 2020.

“To mark the launch, we are pleased to offer an exclusive cost-saving offer to every client who engages our sterility test services in the first 12 months. We would also like to extend an open invitation to visit our new facilities and discuss how our full-service microbiology offering can help to achieve individual safety goals,” adds Fernandes.

RSSL’s new sterility testing service is part of its comprehensive range of critical assessment services for manufacturers of sterile products. This complete biopharmaceutical testing package also includes microscopy to reduce the risks of particulate contamination, as well as endotoxin to analyse potential pyrogen contamination. 

To find out more about our new sterility testing service or to discuss your sterility testing requirements with one of our specialists please contact us our team on 0118 918 4076 or via enquiries@rssl.com. 

Link to press release on RSSL website: https://www.rssl.com/news-and-events/news/pharmaceutical-and-biopharmaceutical/2019/new-sterility-testing  

 

First Create The Media: New Report Showcases 50 Female Trailblazers Shaping UK Bioscience

Released today by BioBeat, the sixth annual 50 Movers and Shakers in BioBusiness report highlights the women who are the trailblazers and trendsetters shaping the future of the UK life sciences sector. The report paints a picture of the UK as a vibrant hub for bioscience for creating life-changing advances.

Read the rest of entry »

Mary Ann Liebert Publishers: PHAGE: Therapy, Applications, and Research

The only peer-reviewed journal dedicated to bacteriophage research and its applications in medicine, agriculture, aquaculture, veterinary applications, animal production, food safety, and food production.

Read the rest of entry »

Leaf Expression Systems Launch First Line of Hypertrans® Research Products

29 May 2019: Norwich, UK Leaf Expression Systems, a contract development and manufacturing organisation specialising in the plant-based expression and production of proteins, vaccines, metabolites and complex natural proteins, has announced the launch of its online list of products available for purchase by researchers working within the life sciences and agricultural industries.

Read the rest of entry »

World Courier: How can Direct-to-Patient Services Reduce the Burden on Traditional Healthcare?

Ageing populations and an increasing number of people living with long term chronic conditions are prompting healthcare systems worldwide to look again at how – and where – they provide care. 

Read the rest of entry »

HemaCare and Tissue Solutions Announce Strategic Partnership to Expand Access to Human Disease-State Samples

(Los Angeles, CA and Glasgow U.K. – March 28, 2019) HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, and Tissue Solutions Ltd, a leading global provider of diseased human biosamples for research, today announced their partnership to supply customers with an expanded selection of well-qualified disease-state biomaterials in fresh, frozen, and FFPE formats.

Read the rest of entry »

Inivata Achieves Major Milestone with Draft Medicare Local Coverage Determination (LCD) for InVisionFirst™Lung Liquid Biopsy Test

Draft Coverage Supports the Use of InVisionFirst-Lung for Aiding in the Management of Patients with Advanced Non-Small-Cell Lung Cancer . Inivata, a leader in liquid biopsy,  announced on 13 September that Palmetto GBA, a Medicare Administrative Contractor that  evaluates diagnostic technology through its laboratory technology assessment group, MolDx, has published a draft local coverage determination (LCD) for the InVisionFirst-Lung test.

Read the rest of entry »

Pages: Previous1234567NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.